BUILDING A LEADING ONCOLOGY FRANCHISE

DIFFERENTIATED CANDIDATES ADDRESSING CLEAR NEEDS

STRONG FINANCIALS, OPTIMALLY BUILDING VALUE

View our 2018 annual report.

Latest News

MEI Pharma to Present New Clinical Results on ME-401 and ME-344 Programs at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting
MEI Pharma Reports Third Quarter Fiscal Year 2019 Results and Operational Highlights
MEI Pharma to Present at the 18th Annual Needham Healthcare Conference
MEI Pharma to Present at the 29th Annual Oppenheimer Healthcare Conference